Available on-demand. Login or create an account to register to view the recording.

Dr. Stoller will review a pilot study of pharmacy dispensing of methadone, the use of a secure pillbox for take home doses of methadone, and a survey of OTPs regarding extended take home doses of methadone during the COVID-19 pandemic. He will also review upcoming changes to Federal regulations for OTPs, and discuss how treatment access, quality, safety and patient-centeredness can be maintained and improved.

At the end of the seminar learners will be able to:

• Identify at least two innovative ways to increase access to methadone treatment of opioid use disorder.
• Identify pros and cons to making methadone available through pharmacy prescribing.
• Learners will become familiar with the proposed regulatory changes to 42 CFR Part 8, issued in December 2022.

Kenneth B. Stoller, M.D. is a Professor of Clinical Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. He is an addiction psychiatrist who is a well-regarded expert on opioid use disorder, and directs the outpatient addiction treatment program at Johns Hopkins Hospital while also serving as the Behavioral Health Medical Director for Johns Hopkins affiliated health plans. Dr. Stoller developed, evaluated and disseminated models of care geared toward multi-morbid populations that are integrative and promote adherence. His most impactful focus has been on collaborative care models, treatment access, program building, health policy, and healthcare utilization/cost. He developed and disseminated a collaborative opioid prescribing ("CoOP" buprenorphine hub and spoke) model which has received high level attention from SAMHSA, ONDCP, and professional societies, and has been instituted by programs and localities nationwide. Dr. Stoller is deeply-engaged with local, state and national associations and governmental agencies engaged in addressing the opioid epidemic.

Julie Kmiec, DO, FAOAAM - (Moderator) AOAAM Past President Julie Kmiec, DO, graduated from Western University of Health Sciences College of Osteopathic Medicine of the Pacific. She completed her general psychiatry residency training and addiction psychiatry fellowship at Western Psychiatric Institute and Clinic (WPIC) in Pittsburgh, PA. She is currently an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. She is board certified in general and addiction psychiatry. Dr. Kmiec is the Medical Director of the Ambulatory Detoxification Program and Bridge Clinic, as well as the Narcotic Addiction Treatment Program. Her clinical interests include treatment of drug and alcohol withdrawal, prevention of overdose, and pharmacotherapy for the treatment of addictions. Dr. Kmiec’s research involves training healthcare professionals on the implementation of medications for opioid use disorder. She is the Immediate Past President of the American Osteopathic Academy of Addiction Medicine.

Speaker:
Kenneth Stoller, MD

• Johns Hopkins University School of Medicine: Faculty/Employee
• Johns Hopkins HealthCare, LLC (health insurance plans): Medical Director, Behavioral Health
• HHS/SAMHSA: Center for Substance Abuse Treatment National Advisory Council (Special Government Employee)
• American Association for the Treatment of Opioid Dependence (AATOD): Board Member
• Indivior: Paid participant, Overdose Advisory Council: April 2023
• Berkshire Biomedical: Paid consultant on Scientific Advisory Council

Planner & Moderator:
Julie Kmiec, DO

• Moderator has no disclosures.

In accordance with disclosure policies of AOA and the ACCME, every effort has been made to ensure all CME activities are balanced, independent, objective, and scientifically rigorous. These policies include complying with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and resolving all possible conflicts of interest for the Planning committees, Authors, Faculty and staff. All relevant financial relationships have been mitigated.

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Financial Disclosure & Disclaimer: This program receives no commercial financial support.

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by the AOA. In no event will the AOA be liable for any decision made or action taken in reliance upon the information provided through this CME.